Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06700356 · ClinicalTrials.gov registry record · NA
Thalamus Seizure Detection With a Deep Brain Stimulator System
A NA study of Epilepsy; Seizure, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT06700356: Recruiting NA study of Epilepsy; Seizure, sponsored by Mayo Clinic.
NCT06700356 is a NA study of Epilepsy; Seizure that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 5 participants, below the 785-participant average among 4 other Epilepsy; Seizure trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06700356, a NA study of Epilepsy; Seizure, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the feasibility of chronic ambulatory thalamus seizure detection. The sensitivity, specificity, and false alarm rate of thalamus seizure detection will be calculated using recordings from a deep brain stimulation system, assessed relative to concurrent gold-standard video-EEG monitoring collected in the in-patient setting (epilepsy monitoring unit), in 5 patients with drug resistant epilepsy.
Primary Outcome
The sensitivity, specificity, and false alarm rate of thalamus seizure detection will be calculated using recordings from a deep brain stimulation system, assessed relative to concurrent gold-standard video-EEG monitoring collected in the epilepsy monitoring unit, in patients with drug resistant epilepsy.
Conditions Studied
Interventions
- DEVICE Phase 1-Validation of thalamus seizure detection with concurrent video EEG monitoring
- DEVICE Phase 2-DBS Stimulation with Medtronic Percept DBS device-Out Patient
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-05 |
| Phase | NA |
What NCT06700356 shows while recruiting
NCT06700356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 785-participant average among 4 other Epilepsy; Seizure trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Epilepsy; Seizure appearing as the primary indexed condition, and to 2 interventions - of which Phase 1-Validation of thalamus seizure detection with concurrent video EEG monitoring is the first listed.
NCT06700356 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06700356 about?
NCT06700356 is a clinical study titled "Thalamus Seizure Detection With a Deep Brain Stimulator System". The purpose of this study is to determine the feasibility of chronic ambulatory thalamus seizure detection. The sensitivity, specificity, and false alarm rate of thalamus seizure detection will be calculated using recordings from a deep brain stimulation system, assessed relative to concurrent gold-...
What is the current status of trial NCT06700356?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2026-06-01. Estimated completion is 2027-05.
What conditions does trial NCT06700356 study?
This clinical trial studies the following conditions: Epilepsy; Seizure.
What interventions are being tested in trial NCT06700356?
The interventions under investigation include: Phase 1-Validation of thalamus seizure detection with concurrent video EEG monitoring (DEVICE), Phase 2-DBS Stimulation with Medtronic Percept DBS device-Out Patient (DEVICE).
Who is sponsoring clinical trial NCT06700356?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06700356 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy; Seizure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimizing Brain Stimulation Parameters
RECRUITING · NA
-
Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking
RECRUITING · NA
-
Sleep Spindles and Memory in Rolandic Epilepsy
RECRUITING · NA
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI